Taltz vs. Cosentyx: How Do These Rheumatic Drugs Compare?

The U.S. Food and Drug Administration (FDA) has expanded the indication of Eli Lilly and Company’s Taltz (ixekizumab) to include active ankylosing spondylitis (AS).